Sio Capital Management, LLC Hedge Fund

Location: New York, NY

CIK: 0001482416 · Show all filings

Period: Q4 2016 (← Previous) (Next →)

Filing Date: Feb 14, 2017

Total Value: $171M (100.0% shares, 0.0% debt)

Holdings (43)

ACAD ACADIA PHARMACEUTICALS INC 9.5%
Value $16.24M Shares 563,200 Est. Cost Unrealized
QUOTIENT LTD 6.3%
Value $10.83M Shares 2,237,771 Est. Cost $13.82 Unrealized
SNY SANOFI SA 5.0%
Value $8.492M Shares 210,000 Est. Cost $43.75 Unrealized
CERNER CORP 4.1%
Value $7.068M Shares 149,200 Est. Cost Unrealized
GLAXOSMITHKLINE PLC 4.1%
Value $6.963M Shares 180,811 Est. Cost $38.51 Unrealized
GLAXOSMITHKLINE PLC 3.8%
Value $6.547M Shares 170,000 Est. Cost $38.51 Unrealized
PHG KONINKLIJKE PHILIPS NV 3.7%
Value $6.404M Shares 209,502 Est. Cost $28.32 Unrealized
HILL-ROM HOLDINGS INC 3.5%
Value $5.984M Shares 106,594 Est. Cost $52.87 Unrealized
TABULA RASA HEALTHCARE INC 3.4%
Value $5.813M Shares 388,054 Est. Cost $14.32 Unrealized
EW EDWARDS LIFESCIENCES CORP 3.0%
Value $5.154M Shares 55,000 Est. Cost $32.40 Unrealized 0.0%
CAH CARDINAL HEALTH INC 2.9%
Value $5.038M Shares 70,000 Est. Cost $60.99 Unrealized -9.3%
CAH CARDINAL HEALTH INC 2.9%
Value $4.958M Shares 68,885 Est. Cost $60.99 Unrealized -9.3%
LLY ELI LILLY AND CO 2.9%
Value $4.928M Shares 67,000 Est. Cost $64.22 Unrealized 0.0%
ZBH ZIMMER BIOMET HOLDINGS INC 2.8%
Value $4.822M Shares 46,723 Est. Cost $99.44 Unrealized 0.0%
WALGREENS BOOTS ALLIANCE INC 2.8%
Value $4.717M Shares 57,000 Est. Cost Unrealized
AMGN AMGEN INC 2.6%
Value $4.386M Shares 30,000 Est. Cost $114.37 Unrealized 0.0%
ZTS ZOETIS INC 2.5%
Value $4.282M Shares 80,000 Est. Cost Unrealized
ALLERGAN PLC 2.5%
Value $4.2M Shares 20,000 Est. Cost Unrealized
ADVANCED ACCELERATOR APPLICATIONS SA 2.4%
Value $4.103M Shares 153,332 Est. Cost $28.98 Unrealized
ACRS ACLARIS THERAPEUTICS INC 2.2%
Value $3.757M Shares 138,441 Est. Cost $25.50 Unrealized 0.0%
ADAMIS PHARMACEUTICALS CORP 1.9%
Value $3.311M Shares 1,051,063 Est. Cost $4.93 Unrealized
NATUS MEDICAL INC 1.8%
Value $3.162M Shares 90,865 Est. Cost $37.56 Unrealized
PHG KONINKLIJKE PHILIPS NV 1.8%
Value $3.057M Shares 100,000 Est. Cost $28.32 Unrealized
RIGEL PHARMACEUTICALS INC 1.8%
Value $3.007M Shares 1,263,390 Est. Cost $2.14 Unrealized
AMGN AMGEN INC 1.7%
Value $2.924M Shares 20,000 Est. Cost $114.37 Unrealized 0.0%
BSX BOSTON SCIENTIFIC CORP 1.5%
Value $2.606M Shares 120,500 Est. Cost $21.82 Unrealized 0.0%
UNH UNITEDHEALTH GROUP INC 1.5%
Value $2.591M Shares 16,187 Est. Cost $121.12 Unrealized +6.6%
HUM HUMANA INC 1.5%
Value $2.55M Shares 12,500 Est. Cost Unrealized
AETNA INC 1.4%
Value $2.48M Shares 20,000 Est. Cost $124.00 Unrealized
BSX BOSTON SCIENTIFIC CORP 1.4%
Value $2.455M Shares 113,500 Est. Cost $21.82 Unrealized 0.0%
PRGO PERRIGO COMPANY PLC 1.4%
Value $2.441M Shares 29,329 Est. Cost $92.15 Unrealized -5.9%
CHEMOCENTRYX INC 1.4%
Value $2.407M Shares 325,250 Est. Cost $4.49 Unrealized
AMGN AMGEN INC 1.4%
Value $2.402M Shares 16,430 Est. Cost $114.37 Unrealized 0.0%
SYK STRYKER CORP 1.4%
Value $2.396M Shares 20,000 Est. Cost Unrealized
IMMUNOMEDICS INC 1.1%
Value $1.861M Shares 506,978 Est. Cost $3.67 Unrealized
ACTINIUM PHARMACEUTICALS INC 0.8%
Value $1.443M Shares 1,649,078 Est. Cost $1.34 Unrealized
ADAMAS PHARMACEUTICALS INC 0.7%
Value $1.17M Shares 69,215 Est. Cost $16.30 Unrealized
SRPT SAREPTA THERAPEUTICS INC 0.6%
Value $960K Shares 35,000 Est. Cost Unrealized
FLAMEL TECHNOLOGIES SA 0.6%
Value $950K Shares 91,413 Est. Cost $10.39 Unrealized
AEGLEA BIO THERAPEUTICS INC 0.5%
Value $820K Shares 188,485 Est. Cost $4.87 Unrealized
FORWARD PHARMA A/S 0.4%
Value $769K Shares 51,246 Est. Cost $17.92 Unrealized
OASMY OASMIA PHARMACEUTICAL AB 0.3%
Value $512K Shares 182,270 Est. Cost $3.35 Unrealized
BIOPHARMX CORP 0.2%
Value $428K Shares 1,143,400 Est. Cost $0.37 Unrealized